440 related articles for article (PubMed ID: 34590471)
1. Neurodegeneration, memory loss, and dementia: the impact of biological clocks and circadian rhythm.
Maiese K
Front Biosci (Landmark Ed); 2021 Sep; 26(9):614-627. PubMed ID: 34590471
[No Abstract] [Full Text] [Related]
2. Cognitive Impairment and Dementia: Gaining Insight through Circadian Clock Gene Pathways.
Maiese K
Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356626
[TBL] [Abstract][Full Text] [Related]
3. Moving to the Rhythm with Clock (Circadian) Genes, Autophagy, mTOR, and SIRT1 in Degenerative Disease and Cancer.
Maiese K
Curr Neurovasc Res; 2017; 14(3):299-304. PubMed ID: 28721811
[TBL] [Abstract][Full Text] [Related]
4. Novel Treatment Strategies for the Nervous System: Circadian Clock Genes, Non-coding RNAs, and Forkhead Transcription Factors.
Maiese K
Curr Neurovasc Res; 2018; 15(1):81-91. PubMed ID: 29557749
[TBL] [Abstract][Full Text] [Related]
5. Nicotinamide: Oversight of Metabolic Dysfunction Through SIRT1, mTOR, and Clock Genes.
Maiese K
Curr Neurovasc Res; 2020; 17(5):765-783. PubMed ID: 33183203
[TBL] [Abstract][Full Text] [Related]
6. Cognitive impairment with diabetes mellitus and metabolic disease: innovative insights with the mechanistic target of rapamycin and circadian clock gene pathways.
Maiese K
Expert Rev Clin Pharmacol; 2020 Jan; 13(1):23-34. PubMed ID: 31794280
[No Abstract] [Full Text] [Related]
7. Forkhead Transcription Factors: Formulating a FOXO Target for Cognitive Loss.
Maiese K
Curr Neurovasc Res; 2017; 14(4):415-420. PubMed ID: 29149835
[TBL] [Abstract][Full Text] [Related]
8. Targeting the core of neurodegeneration: FoxO, mTOR, and SIRT1.
Maiese K
Neural Regen Res; 2021 Mar; 16(3):448-455. PubMed ID: 32985464
[TBL] [Abstract][Full Text] [Related]
9. Forkhead transcription factors: new considerations for alzheimer's disease and dementia.
Maiese K
J Transl Sci; 2016 Jul; 2(4):241-247. PubMed ID: 27390624
[TBL] [Abstract][Full Text] [Related]
10. Novel nervous and multi-system regenerative therapeutic strategies for diabetes mellitus with mTOR.
Maiese K
Neural Regen Res; 2016 Mar; 11(3):372-85. PubMed ID: 27127460
[TBL] [Abstract][Full Text] [Related]
11. Warming Up to New Possibilities with the Capsaicin Receptor TRPV1: mTOR, AMPK, and Erythropoietin.
Maiese K
Curr Neurovasc Res; 2017; 14(2):184-189. PubMed ID: 28294062
[TBL] [Abstract][Full Text] [Related]
12. The mechanistic target of rapamycin (mTOR) and the silent mating-type information regulation 2 homolog 1 (SIRT1): oversight for neurodegenerative disorders.
Maiese K
Biochem Soc Trans; 2018 Apr; 46(2):351-360. PubMed ID: 29523769
[TBL] [Abstract][Full Text] [Related]
13. Targeting molecules to medicine with mTOR, autophagy and neurodegenerative disorders.
Maiese K
Br J Clin Pharmacol; 2016 Nov; 82(5):1245-1266. PubMed ID: 26469771
[TBL] [Abstract][Full Text] [Related]
14. The trilateral interactions between mammalian target of rapamycin (mTOR) signaling, the circadian clock, and psychiatric disorders: an emerging model.
Singla R; Mishra A; Cao R
Transl Psychiatry; 2022 Aug; 12(1):355. PubMed ID: 36045116
[TBL] [Abstract][Full Text] [Related]
15. Stem cell guidance through the mechanistic target of rapamycin.
Maiese K
World J Stem Cells; 2015 Aug; 7(7):999-1009. PubMed ID: 26328016
[TBL] [Abstract][Full Text] [Related]
16. Control of circadian rhythm on cortical excitability and synaptic plasticity.
Lodovichi C; Ratto GM
Front Neural Circuits; 2023; 17():1099598. PubMed ID: 37063387
[TBL] [Abstract][Full Text] [Related]
17. Nicotinamide as a Foundation for Treating Neurodegenerative Disease and Metabolic Disorders.
Maiese K
Curr Neurovasc Res; 2021; 18(1):134-149. PubMed ID: 33397266
[TBL] [Abstract][Full Text] [Related]
18. Erythropoietin and mTOR: A "One-Two Punch" for Aging-Related Disorders Accompanied by Enhanced Life Expectancy.
Maiese K
Curr Neurovasc Res; 2016; 13(4):329-340. PubMed ID: 27488211
[TBL] [Abstract][Full Text] [Related]
19. Systems Level Understanding of Circadian Integration with Cell Physiology.
Morris AR; Stanton DL; Roman D; Liu AC
J Mol Biol; 2020 May; 432(12):3547-3564. PubMed ID: 32061938
[TBL] [Abstract][Full Text] [Related]
20. SIRT1 activation and its circadian clock control: a promising approach against (frailty in) neurodegenerative disorders.
Ribeiro RFN; Pereira D; de Almeida LP; Silva MMC; Cavadas C
Aging Clin Exp Res; 2022 Dec; 34(12):2963-2976. PubMed ID: 36306110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
